The Claim
In adults with biopsy-proven non-alcoholic fatty liver disease, the absence of portal lymphadenopathy is associated with a 91% negative predictive value for an advanced NAFLD Activity Score (NAS ≥5).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Among adults diagnosed with non-alcoholic fatty liver disease through liver biopsy, those without enlarged lymph nodes near the liver portal have a 91% chance of not having severe liver inflammation or damage as measured by the NAFLD Activity Score.
See the scientific wording
In adults with biopsy-proven non-alcoholic fatty liver disease, the absence of portal lymphadenopathy has a high negative predictive value (91%) for advanced NAFLD Activity Score (NAS ≥5), suggesting it may help rule out severe disease in clinical practice.
When the liver has mild fat buildup and little tissue damage, it does not trigger a strong immune response, so lymph nodes near the liver stay normal-sized. When the liver is severely damaged by fat and inflammation, immune cells gather and cause those lymph nodes to swell.
What the research says
1 studyIf someone has fatty liver disease and no swollen lymph nodes near the liver on a scan, this study suggests they’re probably not in the most serious stage of the disease — so doctors might use this as a simple way to spot low-risk patients without needing a biopsy.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.